Jonathan Hunt

Insider Reports History

Location
Seattle, WA
Signature
/s/ Jonathan Hunt by Chris Nenno, as Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Jonathan Hunt:

Company Role Class Num Shares Value Price $ Report Date Ownership
Perspective Therapeutics, Inc. Chief Accounting Officer Common Stock 59,800 $121,202 $2.03 13 Nov 2025 Direct
Perspective Therapeutics, Inc. Chief Accounting Officer Stock option (right to buy) 75,000 03 Mar 2025 Direct

Insider Reports Filed by Jonathan Hunt

Symbol Company Period Transactions Value $ Form Type Role Filing Time
CATX Perspective Therapeutics, Inc. 13 Nov 2025 1 +$22,295 4 Chief Accounting Officer 17 Nov 2025, 08:01
CATX Perspective Therapeutics, Inc. 03 Mar 2025 1 $0 4 Chief Accounting Officer 05 Mar 2025, 16:28
CATX Perspective Therapeutics, Inc. 25 Nov 2024 4 +$48,974 4 Chief Financial Officer 27 Nov 2024, 07:00
CATX Perspective Therapeutics, Inc. 20 Jun 2024 1 $0 4 Chief Financial Officer 24 Jun 2024, 16:05
CATX Perspective Therapeutics, Inc. 17 Jun 2024 1 +$17,667 4 Chief Financial Officer 18 Jun 2024, 07:48
CATX Perspective Therapeutics, Inc. 31 May 2024 2 +$35,007 4 Chief Financial Officer 03 Jun 2024, 16:05
CATX Perspective Therapeutics, Inc. 18 Dec 2023 1 +$32,338 4 Chief Financial Officer 19 Dec 2023, 19:11
CATX Perspective Therapeutics, Inc. 12 Dec 2023 1 $0 4 Chief Financial Officer 14 Dec 2023, 18:36
CATX Isoray, Inc. 01 Dec 2022 2 +$32,501 4 Chief Financial Officer 05 Dec 2022, 17:09
CATX Isoray, Inc. 21 Jul 2022 1 $0 4 Chief Financial Officer 28 Jul 2022, 21:04
CATX Isoray, Inc. 07 Jun 2022 2 +$11,161 4 Chief Financial Officer 09 Jun 2022, 17:18
CATX Isoray, Inc. 01 Jul 2021 1 $0 4 Chief Financial Officer 06 Jul 2021, 16:25